(131)I–Tositumomab in lymphoma

Radioimmunoconjugates are radioisotope-bound monoclonal antibodies that target radiation specifically to sites of lymphoma involvement. Initial studies of (131)I–tositumomab in non-Hodgkin lymphoma (nhl) have suggested benefit in patients with relapsed or refractory indolent disease. However, the ro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Cheung, M.C., MacEachern, J.A., Haynes, A.E., Meyer, R.M., Imrie, K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Multimed Inc. 2009
Konular:
Practice Guidelines Series
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2768513/
https://ncbi.nlm.nih.gov/pubmed/19862360
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller